TechNavio recognizes the following companies as the key players in Global Osteoporosis Drugs Market: Amgen Inc., Eli Lilly & Co., Merck & Co. Inc.,and Novartis AG.
Commenting on the report, an analyst from TechNavio’s team said: “There has been an increase in awareness of bone education among patients and physicians. Enhanced patient and physician awareness is expected to lead to earlier disease diagnosis and treatment. The acceptability of osteoporosis drugs is expected to rise due to the increasing public awareness. This will probably result in increasing drug penetration. Raising general awareness about osteoporosis has led to an increase in research funding and support for clinical and support services. For instance, May is celebrated as National Osteoporosis Awareness and Prevention Month every year. This has encouraged women and men to start conversations about bone health and family history as the first steps to protecting themselves and future generations from osteoporosis. Similarly, the National Osteoporosis Foundation is the leading health organization dedicated to preventing osteoporosis and broken bones, promoting strong bones for life, and reducing human suffering, through programs of public and clinician awareness, education, advocacy, and research. These collaborations have helped to considerably increase the awareness about osteoporosis drugs.”
According to the report, one of the main drivers in this market is the increase in the global aging population. The number of patients suffering from osteoporosis is increasing owing to the increasing aging population both in developing and developed nations. The prevalence of osteoporosis and the incidence of osteoporotic fractures rise substantially with age, especially after the age of 50 years.
Further, the report states that one of the main challenges is the multiple patent expiries. The shift toward lower-priced drugs will lead to a drop in the market valuations for that drug, reducing the overall market value.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors. For further information on this report, please visit https://www.technavio.com/report/global-osteoporosis-drugs-market-2014-2018
TechNavio, the market research platform of Infiniti Research Ltd., publishes periodic market research reports on niche and emerging technologies. For more information on our market research, please visit https://www.technavio.com/healthcare-chemicals-food-retail
Follow us on Twitter @ Technavio
TechNavio Announces the Publication of its Research Report – Global Osteoporosis Drugs Market 2014-2018
